Argenx SE Files August 2025 6-K Report
Ticker: ARGX · Form: 6-K · Filed: Aug 25, 2025 · CIK: 1697862
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Argenx SE filed its August 2025 6-K, standard procedure for foreign private issuers.
AI Summary
Argenx SE filed a Form 6-K on August 25, 2025, reporting for the month of August 2025. The company, a foreign private issuer, is based in Zwijnaarde, Belgium, and its principal executive offices are located in Amsterdam, the Netherlands. Argenx SE is involved in the biological products sector, specifically focusing on biological products excluding diagnostic substances.
Why It Matters
This filing provides routine updates for Argenx SE as a foreign private issuer, informing investors about its ongoing reporting status and corporate information.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material financial or operational information that would typically increase risk.
Key Players & Entities
- ARGENX SE (company) — Filer
- 001-38097 (company) — Commission File Number
- 20250825 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the registrant may be required to disclose or make public pursuant to the laws of its home country or which it may make or be required to make public pursuant to the laws of any stock exchange on which it has a security listed.
When was this Form 6-K filed?
This Form 6-K was filed on August 25, 2025.
What is the Commission File Number for Argenx SE?
The Commission File Number for Argenx SE is 001-38097.
Where are Argenx SE's principal executive offices located?
Argenx SE's principal executive offices are located at Laarderhoogtweg 25, 1101 EB Amsterdam, the Netherlands.
Does Argenx SE file its annual reports under Form 20-F or Form 40-F?
Argenx SE indicates that it files its annual reports under cover of Form 20-F.
Filing Stats: 288 words · 1 min read · ~1 pages · Grade level 14.2 · Accepted 2025-08-25 07:23:52
Filing Documents
- tm2524211d1_6k.htm (6-K) — 10KB
- tm2524211d1_ex99-1.htm (EX-99.1) — 26KB
- 0001104659-25-082118.txt ( ) — 38KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ARGENX SE Date: August 25, 2025 By: /s/ Hemamalini (Malini) Moorthy Name: Hemamalini (Malini) Moorthy Title: General Counsel